top of page

Antimicrobial Resistance (AMR) Committee

Antimicrobial resistance (AMR) is a growing global health threat, rendering common infections harder to treat and undermining advances in medicine. Driven by factors like overuse of antibiotics and poor infection control, AMR demands urgent action through strengthened stewardship and global cooperation to prevent a post-antibiotic era.

Committee Manager

Olufunbi Olaoye

Committee Manager

Committee Members

Palpouguini Lompo

Researcher

IRSS Clinical Research Unit

Luciano Azevedo

Head of Intensive Care Unit

Einstein Hospital Israelita

Simone Mancini

Sepsis Advocacy & Partnerships

Global Sepsis Alliance

Philippe Anaboli

Vice-President for Education

ISOHA

Stephen Anguva Shikoli

National coordinator

Network of TB champions

Alex Runswick

Director of Policy Advocacy

Results UK

Andreas Berglof

Health Policy Advisor

WaterAid

Tapiwanashe Kujinga

Director

PATAM

Abdul Ghafur

Infectious Diseases Consultant

AMR Declaration Trust

Milka Sokolovic

Director General

European Public Health Alliance

Jens Jäger

EU Health & Research Policy

Helmholtz

Dean Everett

Prof. of Infectious Diseases

Khalifa University (UAE)

Dr. Neil Vezeau

One Health Epidemiologist

Lincoln Memorial University

Anita Kotwani

Professor & Head of Pharmacology

University of Delhi

Stephen Mulupi

LVCT Research Head

LVCT HEALTH

Dr Ishwar Gilada

HIV/ID Consultant

Unison Medicare

Oluwatoni Akinola

AMR Program Manager

DRASA Health Trust

Rohit Malpani

Independent AMR Consultant

GARDP

Prof. Dr. Michael Schloter

Research Unit Director

Helmholtz Munich

Ian Hosein

Consultant Medical Microbiologist

Regional Hospital Tullamore

Fozia Noor Mohamed

Executive Director

OPPD

Chinenyenwa Henshaw

Project Manager

eHealth Africa

King Solomon Martin

Nursing supretender

FRH-DONGA

Edward De Beukelaer

Executive Committee Member

European Homeopathy Committee

Blessina Kumer

Global Public Health Professional

Global Coalition of TB Advocates

Dr Danny D. Gotto

Executive Director

I4DEV

Mark Davis

Teaching & Research Academic

Monash University

Erick Venant

Founder

RBA Initiative

Elizabeth Crawford

Senior BD Manager

iiCON (LSTM)

Rania Sultan

Microbiologist & Epidemiologist

The Flow Company

Guest Experts

Javier Aquiles Hidalgo Acosta

Specialist in critical medicine

Independent

Richard Lupasu Lupasu

Immunization Expert

World Health Organization

Reports of our past events

The Event Report and Recordings of the Hybrid Event on Bridging Science, Advocacy, and Practice: A Unified Approach to Combating Antimicrobial Resistance

No events at the moment

No events at the moment

Insights from Our Blog

bottom of page